Public-registry site landscape for NCT03694444, a Gingivitis study sponsored by Amyndas Pharmaceuticals S.A.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03694444 (registry record) |
| Sponsor | Amyndas Pharmaceuticals S.A. |
| Condition(s) | Gingivitis |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT03694444 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →